Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Dixon

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Blood|October 9, 2015
Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactionsCiara L Freeman, Franck Morschhauser, Laurie Sehn, et al.
Journal of Biopharmaceutical Statistics|January 13, 2023
Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platformMarianne Uguen, Magalie Hilton, Mufiza Farid-Kapadia, et al.
The Lancet. Haematology|May 7, 2017
Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trialAndrew Davies, Francesco Merli, Biljana Mihaljević, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|January 19, 2019
Self-extraction with and without a cervical collar: a biomechanical simulation studyMaría Isabel Hontoria Hernández, Raquel Gordillo Martín, Francisco Javier Serrano Martínez, et al.
Biological Psychiatry|January 25, 2017
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte StudiesDragana Bugarski-Kirola, Thomas Blaettler, Celso Arango, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 2, 2017
Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053)Jason P Appleton, Polly Scutt, Mark Dixon, et al.
The New England Journal of Medicine|December 12, 2022
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell LymphomaMichael J Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, et al.
BMC Emergency Medicine|January 11, 2022
Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trialBronwyn Tunnage, Lisa J Woodhouse, Mark Dixon, et al.
Stroke and Vascular Neurology|June 8, 2023
Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trialJason Philip Appleton, Lisa J Woodhouse, Craig S Anderson, et al.
European Journal of Neurology|October 11, 2024
Pre-hospital transdermal glyceryl trinitrate for transient ischaemic attack: Data from the RIGHT-2 trialJason P Appleton, Mark Dixon, Lisa J Woodhouse, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Blood|October 9, 2015
Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactionsCiara L Freeman, Franck Morschhauser, Laurie Sehn, et al.
Journal of Biopharmaceutical Statistics|January 13, 2023
Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platformMarianne Uguen, Magalie Hilton, Mufiza Farid-Kapadia, et al.
The Lancet. Haematology|May 7, 2017
Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trialAndrew Davies, Francesco Merli, Biljana Mihaljević, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|January 19, 2019
Self-extraction with and without a cervical collar: a biomechanical simulation studyMaría Isabel Hontoria Hernández, Raquel Gordillo Martín, Francisco Javier Serrano Martínez, et al.
Biological Psychiatry|January 25, 2017
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte StudiesDragana Bugarski-Kirola, Thomas Blaettler, Celso Arango, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|August 2, 2017
Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053)Jason P Appleton, Polly Scutt, Mark Dixon, et al.
The New England Journal of Medicine|December 12, 2022
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell LymphomaMichael J Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, et al.
BMC Emergency Medicine|January 11, 2022
Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trialBronwyn Tunnage, Lisa J Woodhouse, Mark Dixon, et al.
Stroke and Vascular Neurology|June 8, 2023
Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trialJason Philip Appleton, Lisa J Woodhouse, Craig S Anderson, et al.
European Journal of Neurology|October 11, 2024
Pre-hospital transdermal glyceryl trinitrate for transient ischaemic attack: Data from the RIGHT-2 trialJason P Appleton, Mark Dixon, Lisa J Woodhouse, et al.
Pageof 5